YNYongcheng Ni

Yongcheng Ni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yongcheng Ni has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Chengyong Liu

    Department of Acupuncture and Moxibustion and Rehabilitation Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing Jiangsu China

    1 shared publication
  • Jun Zhao

    Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing City, Jiangsu Province 210029, China

    1 shared publication
  • Ning Ding

    School of Acupuncture-Moxibustion and Tuina, Nanjing University of Chinese Medicine, 210023 Nanjing, Jiangsu, China

    1 shared publication
  • Qian Xu

    Nanjing University of Chinese Medicine, Nanjing City, Jiangsu Province 210023, China

    1 shared publication
  • Qingbo Wei

    School of Acupuncture‑Moxibustion and Tuina of Nanjing, University of Chinese Medicine, Nanjing, China

    1 shared publication
  • Wanli Xu

    Department of Acupuncture and Moxibustion The First Affiliated Hospital with Nanjing Medical University Nanjing China

    1 shared publication

Latest Publications

  • Open Access

    Acupuncture Alleviates Corneal Inflammation in New Zealand White Rabbits with Dry Eye Diseases by Regulating α7nAChR and NF-κB Signaling Pathway

    by Ning Ding, Qingbo Wei, Qian Xu, Chengyong Liu, Yongcheng Ni, Jun Zhao, Wanli Xu, Weiping Gao

    Purpose. The purpose of this study is to determine the mechanism of improvement in dry eye diseases (DEDs) treated by acupuncture. The inflammatory molecules and related pathways will be analyzed in our study. Methods. In order to establish the animal model for DEDs, healthy New Zealand white rabbits were treated with scopolamine (Scop) hydrobromide for 21 consecutive days. After 21 days, acupuncture, fluorometholone (Flu), and α7nAChR antagonist (α-BGT) treatments were performed, and the Scop injections were continued until day 35. The therapeutic effect of acupuncture on DED inflammation was evaluated by corneal fluorescence staining, tear film rupture time, tear flow measurement, in vivo confocal microscopy (IVCM), corneal histopathology, and cytokine protein chip technology. The influence of acupuncture on the corneal pathology and inflammatory factors ACh, α7nAChR, and NF-κB was detected by enzyme-linked immunosorbent assay (ELISA) and western blot. Results. Compared with the group Scop, acupuncture can significantly reduce corneal staining and increase the tear film rupture time and tear flow, which are accompanied by a decrease in corneal epithelial detachment and lymphocyte infiltration. Acupuncture can relieve the inflammation of corneal stroma and mitigate the expression of proinflammatory factors and chemokines. Acupuncture can upregulate the expression of ACh and α7nAChR and downregulate the expression of NF-κB. Conclusion. Our findings demonstrate that acupuncture can alleviate corneal inflammation in New Zealand white rabbits with DEDs via α7nAChR and NF-κB signaling pathway regulation. The expression indicates that α7nAChR/NF-κB signaling pathway may be active and that acupuncture is a potential therapeutic target for dry eye.